VALNEVA (EPA:VLA) | WebDisclosure

Basculer en Français

8205	Companies
109488	Keywords
51628	Articles
60287	Press releases

Home
Companies
VALNEVA

BRIEF

published on 06/05/2024 at 07:05, 5 months ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

Executive Changes Corporate Update Valneva Shareholder Meeting
PRESS RELEASE

published on 06/05/2024 at 07:00, 5 months ago

Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de direction
Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de direction

Documents Préparatoires Valneva Assemblée Générale Mixte Équipe De Direction Kendra Wergin
PRESS RELEASE

published on 06/05/2024 at 07:00, 5 months ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update
Valneva announces availability of documentation for its Combined Shareholder Meeting on June 26, 2024, along with corporate update including change in General Counsel & Corporate Secretary. Kendra Wergin appointed as successor

Corporate Update Valneva General Counsel Shareholder Meeting Kendra Wergin
BRIEF

published on 05/21/2024 at 07:05, 5 months 15 days ago

Valneva appoints Dr Hanneke Schuitemaker as Scientific Director

Nomination R&D Valneva Vaccines Dr Hanneke Schuitemaker
BRIEF

published on 05/21/2024 at 07:05, 5 months 15 days ago

Valneva nomme le Dr Hanneke Schuitemaker comme Directeur Scientifique

Nomination R&D Valneva Dr Hanneke Schuitemaker Vaccins
PRESS RELEASE

published on 05/21/2024 at 07:00, 5 months 15 days ago

Valneva annonce la nomination du Dr Hanneke Schuitemaker en tant que Directeur Scientifique
Valneva annonce la nomination du Dr Hanneke Schuitemaker en tant que Directeur Scientifique, renforçant ainsi son équipe de direction. Le Dr Schuitemaker apportera son expertise en R&D pour développer des solutions vaccinales innovantes

R&D Valneva Dr Hanneke Schuitemaker Vaccins Directeur Scientifique
PRESS RELEASE

published on 04/18/2024 at 16:01, 6 months 16 days ago

Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research bestätigt Kaufempfehlung für Valneva SE mit Kursziel von €8,60 nach positiven Ergebnissen und Schuldenerlass. Analyse von Analyst Simon Scholes, CFA

Research Update Kaufempfehlung Valneva Simon Scholes Schuldenerlass
BRIEF

published on 04/12/2024 at 10:42, 6 months 22 days ago

Upbeat Valneva Research Update from First Berlin Equity Research Maintains BUY Rating

First Berlin Equity Research Buy Recommendation Financial Strategy Valneva Lyme Disease Vaccine
BRIEF

published on 04/12/2024 at 10:42, 6 months 22 days ago

La mise à jour optimiste de Valneva Research issue de First Berlin Equity Research maintient sa note d'achat

Stratégie Financière Recommandation D'achat Valneva Première Recherche Sur Les Actions À Berlin Vaccin Contre La Maladie De Lyme
PRESS RELEASE

published on 04/12/2024 at 10:37, 6 months 22 days ago

Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms Buy rating on Valneva with a target price of €8.60, following positive guidance revisions and debt extension

First Berlin Equity Research BUY Rating Debt Extension Valneva EUR 8.60

Accesswire

Published on 11/05/2024 at 03:30, 4 hours 16 minutes ago

CORRECTION: Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses
Published on 11/05/2024 at 00:00, 7 hours 46 minutes ago

Axcap Ventures Announces Upsizing of Private Placement
Published on 11/04/2024 at 23:00, 8 hours 46 minutes ago

Jericho Energy Ventures Announces Plan to Separate Hydrogen Platform from Traditional Energy Assets to Maximize Shareholder Value
Published on 11/04/2024 at 23:00, 8 hours 46 minutes ago

APEX/IFSA Global EXPO Showcases the Future of Aviation With Nearly 3,000 Industry ‎Professionals in Attendance
Published on 11/04/2024 at 22:45, 9 hours 1 minute ago

Alphinat Announces a Profit of $160,597 for Fiscal Year Ended August 31, 2023

View all ACCESSWIRE

EQS Group

Published on 11/05/2024 at 07:30, 16 minutes ago

AUSTRIAN POST Q1–3 2024: Successful first three quarters of 2024 with double-digit revenue growth
Published on 11/05/2024 at 07:29, 17 minutes ago

Evotec Announces Sale of API Manufacturing Facility to Monacum Partners
Published on 11/05/2024 at 07:17, 28 minutes ago

La part élevée de véhicules alternatifs se reflète dans le parc automobile
Published on 11/05/2024 at 07:15, 31 minutes ago

Spexis expects SIX to delist shares of Spexis on the SIX exchange imminently.
Published on 11/05/2024 at 07:00, 46 minutes ago

NORMA Group achieves sound level of profitability in third quarter of 2024 despite sluggish market environment

Les Echos

Published on 11/05/2024 at 07:45, 1 minute ago

ALTEN signe un accord définitif pour l'achat de Worldgrid à Atos
Published on 11/04/2024 at 18:13, 13 hours 33 minutes ago

Thales : lancement de l’opération 2024 d’actionnariat salarié
Published on 11/04/2024 at 18:13, 13 hours 33 minutes ago

Thales: Launch of the 2024 Employee Share Ownership Plan
Published on 11/04/2024 at 18:11, 13 hours 34 minutes ago

Monthly disclosure of the total number of shares and voting rights - 31/10/2024
Published on 11/04/2024 at 18:11, 13 hours 34 minutes ago

Déclaration mensuelle des actions et droits de vote – 31/10/2024

View all LES ECHOS COMFI WIRE